Online citations, reference lists, and bibliographies.
← Back to Search

Preparation And In Vitro–in Vivo Evaluation Of Salmon Calcitonin-loaded Polymeric Nanoparticles

Eliza Główka, A. Sapin-Minet, P. Leroy, J. Lulek, P. Maincent
Published 2010 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
The aim of the study was to develop and characterize polymeric nanoparticles as a sustained release system for salmon calcitonin (sCT). Nanoparticles were prepared by a double emulsion solvent evaporation method using Eudragit®RS and two types of a biodegradable poly(lactic-co-glycolic) copolymer (PLGA). It was demonstrated that sCT was incorporated into nanoparticles with encapsulation efficiencies in the range 69–83%. In vitro release studies, unconventionally conducted in 5% acetic acid, showed great differences in sCT release time profiles. Nanoparticles with fast release profile (Eudragit®RS, PLGA/Eudragit®RS) released 80–100% of the encapsulated drug within a few hours. In contrast, the sCT release from pure PLGA nanoparticles was very slow, incomplete and reached only 20% after 4 weeks. In vivo study, conducted in Wistar rats, proved that elevated serum sCT levels could be sustained for 3 days after subcutaneous administration of PLGA nanoparticles and the achieved bioavailability was increased compared to sCT solution.
This paper references
10.1016/J.IJPHARM.2006.01.041
Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
K. Dillen (2006)
10.1016/S0168-3659(98)00084-4
Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
P. Johansen (1998)
10.1016/S8756-3282(02)00688-9
Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS.
M. Zaidi (2002)
10.1248/CPB.54.89
In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
Ping Gao (2006)
10.1021/JS960480L
Factors affecting the in vitro release of recombinant human interferon‐γ (rhIFN‐γ) from PLGA microspheres
J. Yang (1997)
10.1016/S0168-3659(98)00179-5
One-month sustained release microspheres of 125I-bovine calcitonin. In vitro-in vivo studies.
R. Diaz (1999)
10.1016/0168-3659(94)00060-8
Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin
C. Tasset (1994)
10.1016/S0168-3659(01)00533-8
Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
G. Jiang (2002)
10.1016/S8756-3282(02)00715-9
Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis.
J. Body (2002)
10.2165/00024677-200403020-00006
Calcitonin Therapy in Osteoporosis
M. Muñoz-Torres (2004)
10.1016/0378-5173(95)04112-5
Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption
Tsuimin Tsai (1996)
One-month sustained release microspheres
RV Diaz (1999)
Peptide acylation by poly(alpha-hydroxy esters).
A. Lucke (2002)
10.1070/MC2003V013N02ABEH001690
Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification–solvent evaporation
Yulia V. Chernysheva (2003)
10.1159/000184243
Treatment of bone in elderly subjects: calcium, vitamin D, fluor, bisphosphonates, calcitonin.
J. Reginster (1995)
10.1016/S0378-5173(02)00458-1
Stability aspects of salmon calcitonin entrapped in poly(ether-ester) sustained release systems.
R. van Dijkhuizen-Radersma (2002)
10.1016/0168-3659(91)90059-M
In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres
K. C. Lee (1991)
10.1023/A:1015839719618
Degradation of Synthetic Salmon Calcitonin in Aqueous Solution
K. Lee (2004)
10.1016/J.JCONREL.2006.10.023
Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.
C. Damgé (2007)
10.1016/S8756-3282(02)00713-5
Analgesic effect of calcitonin in osteoporosis.
C. Gennari (2002)
10.1016/J.BBAPAP.2005.04.008
Early stages of salmon calcitonin aggregation: effect induced by ageing and oxidation processes in water and in the presence of model membranes.
M. C. Gaudiano (2005)
10.1002/JPS.2600841120
Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats.
P. Sinko (1995)
10.1081/DDC-100102168
Adsorption of calcitonin to glass.
S. Law (1999)
Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-gamma) from PLGA microspheres.
J. Yang (1997)
10.1208/pt020207
Compression, compaction, and disintegration properties of low crystallinity celluloses produced using different agitation rates during their regeneration from phosphoric acid solutions
V. Kumar (2008)
10.1016/0168-3659(96)01332-6
Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide)
R. Mehta (1996)
10.1023/A:1014272816454
Peptide Acylation by Poly(α-Hydroxy Esters)
A. Lucke (2004)
10.1016/S0169-409X(00)00063-6
Oral delivery of salmon calcitonin.
Y. H. Lee (2000)
10.1080/107175401316906892
Preparation and In Vitro Evaluation of Heparin-Loaded Polymeric Nanoparticles
Y. Jiao (2001)
10.1016/J.JCONREL.2007.05.034
Effect of acidic pH on PLGA microsphere degradation and release.
B. S. Zolnik (2007)
10.1007/BF02830562
Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres
B. Dani (2008)
10.1016/S0378-5173(99)00118-0
Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres.
M. Blanco-Prieto (1999)
10.1081/DDC-120014576
Low Molecular Weight Heparin-Loaded Polymeric Nanoparticles: Formulation, Characterization, and Release Characteristics
V. Hoffart (2002)
10.1016/S0736-0266(00)00074-7
Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation.
N. N. Aldini (2001)
10.1016/S0939-6411(97)00056-8
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
M. D. Blanco (1997)
Preparation and in vitro evaluation of heparinloaded polymeric nanoparticles
YY Jiao (2001)



This paper is referenced by
10.1039/c9tb02049g
A thermo-sensitive injectable hydroxypropyl chitin hydrogel for sustained salmon calcitonin release with enhanced osteogenesis and hypocalcemic effects.
P. Yu (2019)
10.3109/02652048.2011.635426
Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation
M. Cetin (2012)
10.3109/03639045.2010.497151
The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process
R. Yang (2011)
10.1007/s11095-011-0517-3
Controlled Release of Octreotide and Assessment of Peptide Acylation from Poly(D,L-lactide-co-hydroxymethyl glycolide) Compared to PLGA Microspheres
A. Ghassemi (2011)
10.1016/j.addr.2009.09.006
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
S. Maher (2009)
10.1016/j.ejpb.2011.06.007
pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
T. Zhang (2011)
Microspheres based on biodegradable functionalized poly(alpha-hydroxy) acids for the controlled release of bioactive proteins and peptides
Amir H. Ghassemi (2011)
10.1016/j.mtchem.2019.08.008
Pentapeptide-decorated silica nanoparticles loading salmon calcitonin for in vivo osteoporosis treatment with sustained hypocalcemic effect
P. Yu (2019)
10.2174/0929867324666171012103559
The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations.
Anutthaman Parthasarathy (2017)
10.1002/APP.45486
Salmon calcitonin‐loaded PLGA microspheres/calcium phosphate cement composites for osteoblast proliferation
Ruixue Wu (2017)
10.1016/J.JDDST.2017.02.004
Preparation, physicochemical characterization and anti-fungal evaluation of the Nystatin-loaded Eudragit RS100/PLGA nanoparticles
Ghobad Mohammadi (2017)
10.1007/s10856-013-5125-9
A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm
Kelsen Bastari (2013)
10.1166/JBN.2014.1878
Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers.
A. Umerska (2014)
10.12677/HJBM.2017.71001
鲑鱼降钙素PLGA微球缓释载体 Salmon Calcitonin-Loaded PLGA Microspheres as a Sustained-Release Vehicle
吴瑞雪 (2017)
10.4155/tde.14.5
Recent developments in protein and peptide parenteral delivery approaches.
Ashaben Patel (2014)
10.1016/j.ijpharm.2014.10.023
Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
A. Umerska (2014)
10.1016/j.ejps.2012.02.024
Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation.
M. Yang (2012)
10.1007/s11095-018-2461-y
Hollow Microparticles as a Superior Delivery System over Solid Microparticles for the Encapsulation of Peptides
Sharad Kharel (2018)
10.1016/j.ejpb.2014.06.011
Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
T. Fan (2014)
10.1515/adms-2016-0022
Bacterial Nanocellulose as a Microbiological Derived Nanomaterial
A. Stanisławska (2016)
10.1016/j.biomaterials.2011.07.057
Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles.
S. Vrignaud (2011)
10.1016/j.ijpharm.2013.01.031
Drug carriers in osteoporosis: preparation, drug encapsulation and applications.
K. Miladi (2013)
Polymeric nanoparticle formulation of octapeptide (NP-OP): in vitro release and in vivo effect in common marmosets, Callithrix jacchus Linn.
T. Nandedkar (2013)
Semantic Scholar Logo Some data provided by SemanticScholar